Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Renal Cell 2Pelvic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Abdominal Neoplasms 1

Interventions

Propofol 2Dexmedetomidine 2contrast agent BR1 1Therapeutics 1Surgical Procedures, Operative 1Sevoflurane 1Ropivacaine 1Paclitaxel 1Nitrous Oxide 1Metastasectomy 1Lidocaine 1Iohexol 1Imatinib Mesylate 1Glycopyrrolate 1Food, Formulated 1Fluorouracil 1FS 069 1Enoxaparin 1Embolization, Therapeutic 1Drug Therapy 1Doxorubicin 1Dietary Supplements 1Cytoreduction Surgical Procedures 1Continuous Positive Airway Pressure 1Cisplatin 1Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abdominal Neoplasms × FS 069 × Clear all
NCT00186953 2011-09-20

Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

St. Jude Children's Research Hospital

Phase 1 Completed
14 enrolled
Gynecologic

Abdominal Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡